Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Mitomycin
×
Genitourinary
×
Clear all
Filters
3
NCT01438112
2021-04-14
BOND
CG Oncology, Inc.
Phase 2/3
Terminated
22 enrolled
NCT01920269
2013-08-09
EMDA/MMC
University of Rome Tor Vergata
Phase 2/3
Completed
331 enrolled